ERBC (ex CERB) has acquired RTC

The European Research Biology Center (ERBC) has acquired the Research Toxicology Center (RTC).

ERBC provides healthcare and chemical professionals a comprehensive range of experimental capabilities and services, from preclinical proof-of-concept to market of any type of drug candidate or chemical compound. Each project is managed by a study director, relying on a multi-disciplinary team of experts, notably in general pharmacology, cardiology, electrophysiology and pathophysiology, and also benefiting from a world-class academic and private network.

RTC is a fully fledged contract research laboratory located near Rome, Italy, with a track record spanning more than four decades. RTC collaborates with a large range of industrial clients including the pharmaceutical, biotech, chemical, agro-chemical and biocide industries.

Oaklins' team in France advised the buyer in this transaction.

Service

M&A buy-side

Parties

“With the help of Oaklins, we are thrilled to join forces and offer a critical mass of credible and efficient alternative to the big CROs. We are proud to be a unique European player in the field. Our partnerships with the pharma, other CROs and independent experts play a key role in driving improvements in the pharmaceutical and chemical industries, delivering better data to regulators as well as improved value to study sponsors. Oaklins' team gave us fantastic support in a complex transaction.

”

Serge Richard

CEO, ERBC

Talk to the deal team

Jean-Paul Ortelli

Senior Advisor

Paris, France
Oaklins France

View profile Get in touch

Amance Pélissier

Associate

Paris, France
Oaklins France

View profile Get in touch

Related deals

BlijWerkt has been acquired by Mentha Capital

Business Support Services | Healthcare | Private Equity

BlijWerkt has been acquired by Mentha Capital

Gilde Healthcare Partners has sold BlijWerkt Groep B.V. to Mentha Capital.

Learn more

Lead Healthcare has successfully raised financing provided by Rabobank

Healthcare

Lead Healthcare has successfully raised financing provided by Rabobank

Lead Healthcare has successfully raised financing provided by Rabobank.

Learn more

Enterprises ImportFab Inc. has been acquired by Labomar S.p.A

Healthcare

Enterprises ImportFab Inc. has been acquired by Labomar S.p.A

Labomar S.p.A., a leading company in the research, development and production of food supplements, medical devices and foods for specific medical and cosmetic purposes, has acquired Enterprises ImportFab Inc., a Canadian firm based in Montréal that operates in the North American pharmaceutical, cosmetic and nutraceutical market. The operation has been carried out in partnership with SIMEST that will participate in the acquisition and will hold a minority share of the Canadian company.

Learn more